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Abstract
-Synuclein is the main component of the intracellular protein aggregates in neurons of patients with
Parkinson’s disease. The occurrence of the disease is associated with oxidative damage. Although it is
known that peroxidative chemistry leads to the aggregation of -synuclein in vitro, the specific amino acid
types of -synuclein involved in this type of aggregation have not been identified. We show, using human
cytochrome c plus H2O2 as the source oxidative stress, that the tyrosines of -synuclein are required for
aggregation. The studies reveal the chemical basis for a crucial step in the aggregation process.
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Parkinson’s disease is one of the most common age-related
neurodegenerative disorders, affecting almost 3% of the
population more than 65 years of age. This devastating dis-
ease, clinically characterized by tremor, rigidity, and bra-
dykinesia, affects more than one million persons in the
United States alone (Lang and Lozano 1998). The symp-
toms are caused by the loss of dopaminergic neurons in the
substantia nigra region of the brain. The few surviving neu-
rons in this region contain Lewy bodies (Holdorff 2002),
intracytoplasmic aggregates composed largely of the protein
-synuclein (Spillantini et al. 1997).
-Synuclein became the focus of Parkinson’s disease re-
search after the discovery of two rare, familial forms of the
disease caused by point mutations in the -synuclein gene
(Polymerpoulos et al. 1997). Although the exact functions
of -synuclein are unknown, two main biochemical activi-
ties have been proposed: regulation of dopamine neuro-
transmission and regulation of dopaminergic synaptic
vesicles. -Synuclein is natively disordered (Weinreb et al.
1996) and has a random-coil circular dichroism spectrum
(Kim 1997), but its -helical content increases from 3% to
63%-70% on binding lipid membranes (Davidson et al.
1998).
The cause of -synuclein aggregation to form Lewy bod-
ies is unknown. However, the production of reactive oxygen
species (ROS) has been suggested as a central event. Oxi-
dative stress is an intracellular imbalance in the pro-oxidant/
antioxidant equilibrium, favoring pro-oxidants (Sies 1991).
The main source of intracellular ROS is the mitochondria
(Boveris et al. 1972; Boveris and Chance 1973), where ROS
are produced during the reduction of oxygen to water. Un-
der conditions of oxidative stress, both ROS and the respi-
ratory chain protein cytochrome c can leak from the mito-
chondria into the cytoplasm (Shigenaga et al. 1994). It has
been suggested that this leakage is facilitated by pores in the
mitochondrial membranes formed by -synuclein (Lashuel
et al. 2002; Volles and Lansbury Jr. 2002). Whatever the
mechanism, cytochrome c co-localizes with -synuclein in
Lewy bodies (Hashimoto et al. 1999).
All cellular components are vulnerable to oxidative
stress. The damage to proteins includes side chain modifi-
cation and main chain fragmentation. Two biological mark-
ers for oxidative damage in proteins are accumulation of
carbonyl groups and dityrosine (Berlett and Stadtman
1997). Dityrosine is a useful marker for protein oxidation
(Giulivi and Davies 1993; Heinecke et al. 1993; Huggins et
al. 1993) and is found in amino acid hydrosylates of brain
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tissue affected by Parkinson’s disease (Pennathur et al.
1999).
There are two proposed mechanisms for dityrosine for-
mation: Fenton chemistry and peroxidase-mediated tyrosyl
radical formation. Fenton chemistry, which generates hy-
droxyl radicals (HO.) from simple transition metal plus
H2O2, was believed (Stadtman 1993) to play a role in dity-
rosine formation. However, recent studies (Kato et al. 2001)
show that HO. is not involved in dityrosine formation, and
may even decrease the yield of dityrosine (Atwood et al.
2004). Oxidative cross-linking of proteins by tyrosine resi-
dues probably occurs through a peroxidase-like mechanism.
The proposed mechanism for the reaction of H2O2 with
ferricytochrome c owes a great deal to what is known about
the reaction of H2O2 with the heme-containing peroxidase
enzymes, especially cytochrome c peroxidase (Erman and
Vitello 2002). This enzyme donates two electrons and two
protons to H2O2, producing two molecules of water and
leaving two free radicals on the enzyme, one heme-based
and the other on a buried tryptophan. The final location of
the radicals on cytochrome c with reaction with H2O2 is less
clear, but spin trap experiments, which indirectly detect free
radicals, suggest that the unpaired electrons end up on ty-
rosines (Barr et al. 1996; Deterding et al. 1998; Chen et al.
2002; Qian et al. 2002). If two adjacent tyrosine radical-
containing molecules interact, a dityrosine-linked dimer
forms. Highlighting the importance of understanding per-
oxidative chemistry is the recent observation that cycloox-
ygenase (a peroxidase family member) plus H2O2 induces
aggregation of A, the protein associated with Alzheimer’s
disease (Nagano et al. 2004).
Hashimoto et al. (1999) were the first to show the aggre-
gation of -synuclein by cytochrome c and H2O2. They also
showed that cytochrome c co-localizes with -synuclein in
intracellular aggregates in neurons from subjects with Par-
kinson’s disease. These results suggest that cytochrome c
plays a role in the oxidative stress-induced aggregation of
-synuclein in Parkinson’s disease. However, the mecha-
nism by which cytochrome c leads to -synuclein aggrega-
tion, including the types of amino acids involved, is un-
known. Barr et al. (1996) and Qian et al. (2002) showed that
radicals formed by the reaction of horse cytochrome c and
H2O2 are centered on tyrosine residues using electron spin
trapping. Deterding et al. (1998) first showed with mass
spectrometry and spin trapping studies that a free radical
formed on horse cytochrome c under oxidative conditions
can be transferred to tyrosine-containing peptides and that
tyrosines are required for transfer. Nevertheless, the residue
types involved in peroxidative aggregation of -synuclein
remained unknown.
From these data about cytochrome c oxidation and tyro-
sine we hypothesized that tyrosine residues on -synuclein
are important for the peroxidative aggregation of -sy-
nuclein. The hypothesis was tested by making an -sy-
nuclein variant in which all the tyrosines were changed to
phenylalanines and testing the variant under the same con-
ditions used by Hashimoto et al. (1999).
Results
Wild-type -synuclein aggregates in the presence
of cytochrome c and H2O2
Recombinant wild-type -synuclein was incubated with cy-
tochrome c in the presence or absence of H2O2. Coomassie
Brilliant Blue staining (Fig. 1) and immunoblot analysis
(Fig. 2) showed that -synuclein aggregates to an SDS-
stable species in the presence of H2O2 plus recombinant
human cytochrome c. The data in lane 2 of both figures
show that H2O2 is required for the aggregation of
-synuclein. Comparing the data in Figures 1 and 2 indi-
cates that the band at just above 20.1 kD in lane 3 of Figure
1 is the cytochrome c dimer from self-induced peroxidative
aggregation, as was observed by Hashimoto et al. (1999).
Also, as observed by these investigators and confirmed
by us (data not shown) -synuclein fails to aggregate in the
presence of 1 mM H2O2 alone. To prove that the interac-
tion between cytochrome c and H2O2 is required for
-synuclein aggregation we performed the complete reac-
tion in the presence of cyanide, which binds the heme iron
of cytochrome c, blocking the reaction of cytochrome c
with H2O2. Aggregation is inhibited by cyanide (data
not shown). The results reported here with human cyto-
chrome c and wild-type -synuclein confirm and extend the
results of Hashimoto et al. (1999), who used horse heart
cytochrome c.
Figure 1. -Synuclein aggregates in the presence of H2O2 and recombi-
nant human cytochrome c. Purified recombinant wild-type human
-synuclein (-syn) (10 M) was incubated at 37°C for 1 h either alone
(lane 1) or with 100 M recombinant human cytochrome c (Cc; lanes 2, 3)
in the presence (lane 3) or absence (lanes 1, 2) of 1 mM H2O2. The gel was
stained with Coomassie Brilliant Blue.
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The no-tyrosine variant of -synuclein fails to
aggregate in the presence of cytochrome c and H2O2
Recombinant no-tyrosine -synuclein was incubated with
recombinant human cytochrome c under the same condi-
tions as the experiments shown in Figure 1. Coomassie
Brilliant Blue staining showed that no-tyrosine -synuclein
does not aggregate in the presence of recombinant human
cytochrome c and H2O2 (Fig. 3). As described above, the
presence of the cytochrome c dimer at just above 20.1 kD in
lane 1 of Figure 3 proves the reaction was aggregation-
competent, and, like the wild-type protein, the variant failed
to aggregate in the presence of H2O2 alone. Our results
establish for the first time that tyrosine residues are required
for peroxidative aggregation of -synuclein.
Discussion
-Synuclein aggregation is associated with several neuro-
degenerative disorders, but despite intense investigation, the
mechanism of aggregation and the residue types involved
are unknown. It is known, however, that -synuclein forms
SDS stable oligomers when exposed to oxidizing agents
(Souza et al. 2000). Hashimoto et al. (1999) showed that
-synuclein aggregates in the presence of cytochrome c and
H2O2. Cytochrome c forms tyrosyl radicals when exposed
to H2O2 (Barr et al. 1996), and these radicals can be trans-
ferred to tyrosine residues on other proteins (Deterding et al.
1998). On the basis of these observations we hypothesized
that tyrosines are key residues in the aggregation of
-synuclein in the presence of cytochrome c and H2O2. The
data in Figures 1 and 2, which were acquired under the same
conditions used by Hashimoto et al., shows that both cyto-
chrome c and H2O2 are required for -synuclein aggrega-
tion, and the inhibition of the reaction by cyanide shows
direct involvement of the heme in peroxidative aggregation
of -synuclein by cytochrome c.
-Synuclein has four tyrosines (at positions 39, 125, 133,
and 136). To investigate the role of these tyrosines in the
reaction, we converted the four tyrosines in -synuclein to
phenylalanines. To rule out structural changes in the no-
tyrosine variant, we analyzed its secondary structure by us-
ing circular dichroism spectropolarimetry (data not shown).
The no-tyrosine variant has a random coil spectrum, iden-
tical to that of wild-type -synuclein.
As shown in Figure 3, no-tyrosine -synuclein remains
monomeric in the presence of cytochrome c and H2O2.
These results prove that tyrosines are required for the per-
oxidative aggregation of -synuclein in the presence of
H2O2 and cytochrome c and are consistent with results from
studies of cyclooxygenase-induced peroxidative aggrega-
tion of A, a protein associated with Alzheimer’s disease
(Nagano et al. 2004). On the other hand, when Cu(II) and
H2O2 are used to produce ROS through the Fenton reaction,
tyrosines are not required for the oxidative aggregation of
-synuclein (Norris et al. 2003). This discrepancy points to
the importance of the ROS source in the mechanism of
aggregation. We have assumed that the aggregates observed
in SDS gels are covalently cross-linked. We are currently
Figure 3. No-tyrosine -synuclein does not aggregate in the presence of
cytochrome c and H2O2. No-tyrosine (Y, 10 M) -synuclein plus re-
combinant cytochrome c (Cc, 10 M) were incubated at 37°C for 1 h, with
1 mM H2O2 (lane 1). No-tyrosine -synuclein (10 M) was incubated at
37°C for 1 h with 1 mM H2O2 alone (lane 2) or with 50 M recombinant
human cytochrome c alone (lane 3). The gel was stained with Coomassie
Brilliant Blue.
Figure 2. Anti--synuclein immunoblot analysis for the aggregation of
wild-type -synuclein in the presence of cytochrome c and 1 mM H2O2.
Recombinant wild-type human -synuclein (10 M) was incubated at
37°C for 1 h either alone (lane 1) or with 100 M recombinant human
cytochrome c (lanes 2, 3) in the presence (lane 3) or absence (lanes 1, 2)
of 1 mM H2O2.
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testing this assumption and determining which of the four
tyrosines are responsible for aggregation.
In summary, we have shown that tyrosines in -synuclein
are required for -synuclein’s peroxidative aggregation, and




Recombinant human cytochrome c and human -synuclein were
expressed in Escherichia coli and purified as described (Morar et
al. 2001; Olteanu et al. 2003).
Site-directed mutagenesis
The human -synuclein variant with all the tyrosines mutated to
phenylalanines, no-tyrosine -synuclein, was made by using the
QuikChange Site-Directed Mutagenesis Kit (Stratagene). The con-
version was performed in three steps: (Y39F), (Y125F), and
(Y133, 136F). The mutagenic oligonucleotides were synthesized at
the Nucleic Acid Core Facility in the UNC Lineberger Cancer
Center. The nucleotide sequence was confirmed by the UNC Au-
tomated Sequencing Facility. The concentration of the variant was
determined by using the same absorbance coefficient as for the
wild-type protein (5800 M−1 cm−1 at 276 nm calculated by using
ExPASy (http://us.expasy.org). Because the no-tyrosine variant
contains neither tyrosine nor tryptophan, the protein concentration
was confirmed by SDS-PAGE analysis.
Aggregation assays of cytochrome c and -synuclein
in the presence of H2O2
Aggregation assays were performed as described by Hashimoto et
al. (1999). Briefly, 100-M cytochrome c and 10-M -synuclein
(the wild-type protein or the no-tyrosine variant) were incubated in
a total volume of 100 L of PBS (100 mM NaCl, 20 mM KH2PO4,
80 mM Na2HPO4 · 2 H2O at pH 7.4), with or without 1 mM H2O2,
at 37°C, for 1 h. The reaction mixture was analyzed by SDS-
PAGE, at 200 V, for 45 min, in a 12% gel. Immunoblot analysis
was performed as described by Hashimoto et al. (1999). Samples
were electrophoresed at 200 V. The gel was blotted onto a nitro-
cellulose membrane that had been soaked for 10 min in methanol.
The gel was blotted for 1 h in transfer buffer (3.02 g of Tris base,
14.4 g of glycine, 1 L of H2O). The membrane was blocked in 5%
(w/v) dried milk in TBST (10 mL 1 M Tris at pH 7.5, 30 mL 5 M
NaCl, 500 L 0.05% Tween 20), at room temperature, for 1 h,
followed by incubation with mouse anti--synuclein antibody
(LB509, dilution 1:1000) (Zymed Laboratories Inc.), for 1 h, at
37°C, in TBST plus 5% (w/v) dried milk. The membrane was then
incubated with horseradish peroxidase rabbit antimouse secondary
antibody (dilution 1:3000) (Zymed Laboratories Inc.) for 1 h, at
room temperature. Protein bands were visualized by using the ECL
Western blot detection kit (Amersham).
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